Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

580
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
580
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

356
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
356
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

1.0K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.0K
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

312
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
312
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

677
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
677
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

1.4K
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Simple and Versatile Toolkit for Genetic Manipulation of <i>Bacillus licheniformis</i>.

ACS synthetic biology·2025
Same author

[Pathogenicity analysis and genetic counseling for a hemizygous c.1042-10G>C variant of SLC9A7 gene].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics·2025
Same author

[Pathogenicity analysis of a novel PADI6 gene variant associated with female infertility].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics·2025
Same author

Introducing anti-hydrogen evolution sites by hydrophilic metalloporphyrin coatings for stabilizing Zn metal anodes.

Journal of colloid and interface science·2025
Same author

Cardiac surgery timing on the prognosis of patients with infective endocarditis.

Journal of cardiothoracic surgery·2025
Same author

Association of embolization branch selection on middle meningeal artery embolization for chronic subdural hematoma: a secondary analysis of the MAGIC-MT trial.

Neuroradiology·2025
Same journal

Unraveling the enigma: Post-translational modifications in psychiatric disorders and their regulatory mechanisms.

Journal of translational internal medicine·2026
Same journal

Immunoglobulin κ drives liver regeneration by stabilizing MYLK to maintain cytoskeletal integrity and promote hepatocyte proliferation.

Journal of translational internal medicine·2026
Same journal

Exercise may serve as a potential preventive strategy for mitochondria influencing the occurrence of heart failure with preserved ejection fraction.

Journal of translational internal medicine·2026
Same journal

Dual role of intratumoral microbiota: From colorectal cancer progression to therapeutic opportunities.

Journal of translational internal medicine·2026
Same journal

Inflammation, metabolism, and aging in heart failure with preserved ejection fraction: Mechanisms and treatment perspectives.

Journal of translational internal medicine·2026
Same journal

Joint association of the frailty index and phenotypic age with all-cause and cause-specific mortality: A prospective cohort study.

Journal of translational internal medicine·2026
See all related articles

Related Experiment Video

Updated: Dec 7, 2025

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

19.1K

COVID-19 and Tuberculosis.

Heng Yang1, Shuihua Lu1

  • 1Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.

Journal of Translational Internal Medicine
|September 28, 2020
PubMed
Summary
This summary is machine-generated.

This review summarizes the latest advances in coronavirus disease 2019 (COVID-19) epidemiology, pathogenesis, and clinical features. It also explores the characteristics of co-infection with tuberculosis (TB) and emerging infectious diseases.

Keywords:
COVID-19SARS-CoV-2clinical featuresemerging infectious diseasesradiologic manifestationtuberculosis

More Related Videos

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

2.1K
An Experimental Model to Study Tuberculosis-Malaria Coinfection upon Natural Transmission of Mycobacterium tuberculosis and Plasmodium berghei
09:02

An Experimental Model to Study Tuberculosis-Malaria Coinfection upon Natural Transmission of Mycobacterium tuberculosis and Plasmodium berghei

Published on: February 17, 2014

20.1K

Related Experiment Videos

Last Updated: Dec 7, 2025

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

19.1K
An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

2.1K
An Experimental Model to Study Tuberculosis-Malaria Coinfection upon Natural Transmission of Mycobacterium tuberculosis and Plasmodium berghei
09:02

An Experimental Model to Study Tuberculosis-Malaria Coinfection upon Natural Transmission of Mycobacterium tuberculosis and Plasmodium berghei

Published on: February 17, 2014

20.1K

Area of Science:

  • Public Health
  • Infectious Diseases
  • Epidemiology

Background:

  • The World Health Organization declared coronavirus disease 2019 (COVID-19) a pandemic on March 11, 2020, due to its rapid spread and severity.
  • Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and COVID-19 have garnered significant global attention, impacting public health and economies.
  • Tuberculosis (TB) remains a primary communicable respiratory disease, posing a continuous threat to global health.

Purpose of the Study:

  • To review the latest advancements in COVID-19 epidemiology, pathogenesis, and clinical characteristics.
  • To examine the limited data on the risks and outcomes for patients co-infected with TB and COVID-19.
  • To provide insights into managing current epidemics by understanding the characteristics of TB co-infections with emerging diseases.

Main Methods:

  • Literature review focusing on recent studies and data.
  • Analysis of epidemiological trends and clinical presentations of COVID-19.
  • Synthesis of information regarding co-infections of tuberculosis with viral and emerging infectious diseases.

Main Results:

  • COVID-19 presents significant global public health and economic challenges.
  • Data on the concurrence of TB and COVID-19 is limited, but viral co-infections can exacerbate TB.
  • Previous co-infections, like tuberculosis and influenza, have been associated with increased mortality.

Conclusions:

  • Understanding COVID-19's characteristics is crucial for managing the current pandemic.
  • Further research is needed to clarify the risks associated with TB and COVID-19 co-infection.
  • Insights from past co-infections can inform strategies for managing concurrent TB and emerging infectious diseases.